Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Retrovirology|September 25, 2015
Variants in the CYP7B1 gene region do not affect natural resistance to HIV-1 infectionManuela Sironi, Mara Biasin, Chiara Pontremoli, et al.Dermatopathology (Basel, Switzerland)|September 25, 2021
Artificial Intelligence in Dermatopathology: New Insights and PerspectivesGerardo Cazzato, Anna Colagrande, Antonietta Cimmino, et al.AIDS (London, England)|February 26, 2013
Endoplasmic reticulum aminopeptidase 2 haplotypes play a role in modulating susceptibility to HIV infectionMara Biasin, Manuela Sironi, Irma Saulle, et al.Plos Genetics|March 29, 2014
An evolutionary analysis of antigen processing and presentation across different timescales reveals pervasive selectionDiego Forni, Rachele Cagliani, Claudia Tresoldi, et al.The Journal of Antimicrobial Chemotherapy|August 8, 2006
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatmentStefano Aquaro, Roberta D'Arrigo, Valentina Svicher, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2011
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates)Piero L Almasio, Sergio Babudieri, Giorgio Barbarini, et al.BMC Infectious Diseases|July 16, 2005
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER CohortCarlo Torti, Giuseppe Lapadula, Salvatore Casari, et al.Microbes and Infection|September 23, 2016
A 6-amino acid insertion/deletion polymorphism in the mucin domain of TIM-1 confers protections against HIV-1 infectionMara Biasin, Manuela Sironi, Irma Saulle, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2005
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) studyCarlo Torti, Eugenia Quiros-Roldan, Mario Regazzi, et al.Plos One|October 4, 2007
The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infectionEleonora Castelletti, Sergio Lo Caputo, Louise Kuhn, et al.Pageof 7